2020 | | Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease | 박해심, 예영민 |
2019 | | Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study | 박해심, 신유섭, 예영민 |
2022 | | Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU) | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
2020 | | Increasing Prevalence and Mortality of Asthma With Age in Korea, 2002-2015: A Nationwide, Population-Based Study | 박해심, 예영민 |
2023 | | Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease | 박해심, 예영민 |
2020 | | Non-episodic Angioedema With Eosinophilia Successfully Treated With Reslizumab | 박해심, 예영민 |
2021 | | Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma | 박해심, 신유섭, 예영민, 최영우 |
2020 | | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea | 박해심, 신유섭, 예영민 |
2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2023 | | Real-World Disease Burden of Chronic Urticaria and Vaccine Hesitancy | 예영민 |
2021 | | Risk factors predicting Severe Asthma exacerbations in adult asthmatics: A real-world clinical evidence | 박해심, 신유섭, 예영민 |
2019 | | Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis | 남동호, 박해심, 신유섭, 예영민, 이소희 |
2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study | 박해심, 예영민 |
2021 | | Screening for autoimmune comorbidities in patients with chronic spontaneous urticaria: Which tests to whom | 예영민 |
2021 | | Serum Human β-Defensin 2 Is Increased in Angioedema Accompanying Chronic Spontaneous Urticaria | 박해심, 예영민 |
2024 | | Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis | 예영민 |
2020 | | Serum potential biomarkers according to sputum inflammatory cell profiles in adult asthmatics | 박해심, 예영민 |
2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2021 | | Severe cutaneous adverse reactions to anti-tuberculosis drugs in korean patients | 예영민 |
2019 | | Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea | 예영민 |
2023 | | Skin Test–Guided Strategy to Select Alternative Iodinated Contrast Media in Patients With Immediate Hypersensitivity Reaction: A Prospective Confirmative Study | 예영민 |
2022 | | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea | 박해심, 예영민 |
2020 | | The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management | 예영민 |
2020 | | The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria | 예영민 |
2023 | | Treatment with biological products for chronic urticaria | 예영민 |
2023 | | Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study | 예영민, 이영수 |